首页 | 本学科首页   官方微博 | 高级检索  
检索        

肛周脓肿病原菌分布及耐药性分析
引用本文:张志刚,;辛学知,;李志,;秦一翔.肛周脓肿病原菌分布及耐药性分析[J].中国肛肠病杂志,2014(8):35-37.
作者姓名:张志刚  ;辛学知  ;李志  ;秦一翔
作者单位:[1]山东中医药大学,山东济南250014; [2]山东省千佛山医院肛肠科,山东济南250014
摘    要:为探讨肛周脓肿病原菌分布及对常用抗菌药物的耐药性,选取山东省千佛山医院肛肠科2013年9月23日至2014年4月23日收治58例肛周脓肿患者进行研究,对其脓液进行革兰染色、病原菌培养及药敏试验。结果显示,58例患者中,4例未培养出细菌,其余54例共分离出病原菌67株(其中革兰阴性菌54株,占80.6%;革兰阳性菌13株,占19.4%);检出菌株数居首位的为大肠埃希菌(41株,61.2%),其次为肺炎克雷伯菌(7株,10.4%)。大肠埃希菌及肺炎克雷伯菌对常用抗菌药物敏感率较低,耐药性较高,尤其是对氨苄西林的耐药性较强,但对头孢西丁、美罗培南、亚胺培南、阿米卡星、厄他培南、替卡西林/克拉维酸、哌拉西林/他唑巴坦高度敏感。多重耐药11例,其中9例为大肠埃希菌感染多重耐药(ESBLS阳性),2例为葡萄球菌感染多重耐药。9例ESBLS阳性大肠埃希菌感染者对头孢噻肟100%耐药,对头孢西丁、美罗培南、亚胺培南、阿米卡星、哌拉西林/他唑巴坦、厄他培南、替卡西林/克拉维酸未见耐药。结果表明,肛周脓肿病原菌以革兰阴性杆菌为主,治疗时应首选抗革兰阴性杆菌的药物,并采取积极办法应对病原菌的多重耐药,可选替卡西林/克拉维酸、哌拉西林/他唑巴坦等含酶抑制剂的抗菌药物。

关 键 词:肛周脓肿  细菌学检验  耐药性  多重耐药

Analysis on the Distribution and Drug-resistance of Pathogens at Perianal Abscess
Institution:ZHANG Zhi-gang ,XIN Xue-zhi ,LI Zhi ,QIN Yi-xiang(1 Shandong TCM University ,Jinan ,Shadong 250014 ;2Oept. of Coloproctology, Qianfoshan Hospital of Shandong Province ,dinan ,Shandong 250014)
Abstract:In order to investigate the distribution and drug-resistance of pathogens at perianal abscess authors recruited 58 patients with perianal abscess treated in Qianfoshan hospital of Shandong province from 2013-09-23 to 2014-04-23 ,and took G staining,pathogen culture and drug-sensitive test for patient's pus.As results, from the pus in 54 of 58 cases 67 strains of pathogens were isolated included 54 strains of G- bacteria accounted 80.6% ,while,G^+ , 13,19.4% ;isolated pathogens in turn was E.coli (41 strains,accounted 61. 2%), Klebsiella pneumoniae (7,10.4%) ,which both all had higher drug-resistomce and lower sensitivity to common antibacterials,especialy,higher drug-resistance to Ampicillin,high sensitive to Cefoxitin,Meropenem, Imipenem, Amikacin, Ertapenem, Ticarcillin/Clavulanic acid, Piperacillin/Tazobactam; 11 cases were of multi drug-resistance to E.coli (9 of ESBLs+ ,2 of multi drug-resistance to Staphylococcus ),the 9 cases of ESBLs+ were only of drugs-resistance to Cefotaxime,without drugs-resistance to other drugs.Results show that owing to perianal abscess pathogens being predominated by G- bacteria it should be to first choice anti-G- bacteria drugs for treatment of abscess, and actively to cope multi drug-resistance, thus some contained-enzyme inhibitive anti-bacteria drugs like as Ticarcillin/clavulanic acid, Piperacillin/ Tazobactam,etc could be selected.
Keywords:Perianal abscess  Bacterology assay  Drug-resistance  Multi drugs-resistance
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号